BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 20603199)

  • 1. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum.
    Fatmawati S; Shimizu K; Kondo R
    Fitoterapia; 2010 Dec; 81(8):1033-6. PubMed ID: 20603199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum.
    Luo J; Zhao YY; Li ZB
    J Asian Nat Prod Res; 2002 Jun; 4(2):129-34. PubMed ID: 12067158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors.
    Fatmawati S; Shimizu K; Kondo R
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7295-7. PubMed ID: 22047696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure elucidation and complete NMR spectral assignments of three new lanostanoid triterpenes with unprecedented Delta(16, 17) double bond from Ganoderma lucidum.
    Guan SH; Yang M; Wang XM; Xia JM; Zhang ZM; Liu X; Guo DA
    Magn Reson Chem; 2007 Sep; 45(9):789-91. PubMed ID: 17640004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum.
    Fatmawati S; Shimizu K; Kondo R
    Planta Med; 2010 Oct; 76(15):1691-3. PubMed ID: 20379959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New triterpenoids from the fruiting bodies of Ganoderma lucidum and their bioactivities.
    Liu DZ; Zhu YQ; Li XF; Shan WG; Gao PF
    Chem Biodivers; 2014 Jun; 11(6):982-6. PubMed ID: 24934684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum.
    Fatmawati S; Shimizu K; Kondo R
    Phytomedicine; 2011 Sep; 18(12):1053-5. PubMed ID: 21596546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells.
    Lee I; Seo J; Kim J; Kim H; Youn U; Lee J; Jung H; Na M; Hattori M; Min B; Bae K
    J Nat Prod; 2010 Feb; 73(2):172-6. PubMed ID: 20039640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the ganoderic acid, a new constituents from the fruiting body of Ganoderma lucidum (Fr.) Karst].
    Wang FS; Cai H; Yang JS; Zhang YM; Hou CY; Liu JQ; Zhao MJ
    Yao Xue Xue Bao; 1997 Jun; 32(6):447-50. PubMed ID: 11596326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new triterpene from the fruiting bodies of Ganoderma lucidum.
    Chen M; Zhang M; Sun S; Xia B; Zhang HQ
    Yao Xue Xue Bao; 2009 Jul; 44(7):768-70. PubMed ID: 19806918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum.
    Tung NT; Cuong TD; Hung TM; Lee JH; Woo MH; Choi JS; Kim J; Ryu SH; Min BS
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1428-32. PubMed ID: 23357630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity.
    Seo HW; Hung TM; Na M; Jung HJ; Kim JC; Choi JS; Kim JH; Lee HK; Lee I; Bae K; Hattori M; Min BS
    Arch Pharm Res; 2009 Nov; 32(11):1573-9. PubMed ID: 20091270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum.
    Lee I; Ahn B; Choi J; Hattori M; Min B; Bae K
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6603-7. PubMed ID: 21924611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extraction of triterpenoids from fruiting [corrected] bodies of Ganoderma lucidum by supercritical fluid extraction].
    Song SH; Jia XB; Chen Y; Chen B; Wang LJ; Zhao CL
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2104-7. PubMed ID: 19066051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lanostane triterpenes from Ganoderma lucidum suppress the adipogenesis in 3T3-L1 cells through down-regulation of SREBP-1c.
    Lee I; Kim J; Ryoo I; Kim Y; Choo S; Yoo I; Min B; Na M; Hattori M; Bae K
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5577-81. PubMed ID: 20702092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH.
    Lin YX; Sun JT; Liao ZZ; Sun Y; Tian XG; Jin LL; Wang C; Leng AJ; Zhou J; Li DW
    Fitoterapia; 2022 Apr; 158():105161. PubMed ID: 35217118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum.
    Min BS; Gao JJ; Hattori M; Lee HK; Kim YH
    Planta Med; 2001 Dec; 67(9):811-4. PubMed ID: 11745016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triterpenoids from Ganoderma lucidum and their cytotoxic activities.
    Li P; Deng YP; Wei XX; Xu JH
    Nat Prod Res; 2013; 27(1):17-22. PubMed ID: 22263904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum.
    Liu J; Kurashiki K; Shimizu K; Kondo R
    Biol Pharm Bull; 2006 Feb; 29(2):392-5. PubMed ID: 16462054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constituents from the fruiting bodies of Ganoderma applanatum and their aldose reductase inhibitory activity.
    Lee SH; Shim SH; Kim JS; Kang SS
    Arch Pharm Res; 2006 Jun; 29(6):479-83. PubMed ID: 16833015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.